Ardent Health Statistics
Total Valuation
Ardent Health has a market cap or net worth of $1.28 billion. The enterprise value is $2.95 billion.
| Market Cap | 1.28B |
| Enterprise Value | 2.95B |
Important Dates
The last earnings date was Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ardent Health has 143.19 million shares outstanding. The number of shares has increased by 9.52% in one year.
| Current Share Class | 143.19M |
| Shares Outstanding | 143.19M |
| Shares Change (YoY) | +9.52% |
| Shares Change (QoQ) | -0.21% |
| Owned by Insiders (%) | 1.25% |
| Owned by Institutions (%) | 20.99% |
| Float | 24.54M |
Valuation Ratios
The trailing PE ratio is 6.18 and the forward PE ratio is 6.91.
| PE Ratio | 6.18 |
| Forward PE | 6.91 |
| PS Ratio | 0.20 |
| Forward PS | 0.19 |
| PB Ratio | 1.03 |
| P/TBV Ratio | 4.73 |
| P/FCF Ratio | 8.12 |
| P/OCF Ratio | 3.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.55, with an EV/FCF ratio of 18.72.
| EV / Earnings | 14.38 |
| EV / Sales | 0.47 |
| EV / EBITDA | 5.55 |
| EV / EBIT | 7.79 |
| EV / FCF | 18.72 |
Financial Position
The company has a current ratio of 2.08, with a Debt / Equity ratio of 1.40.
| Current Ratio | 2.08 |
| Quick Ratio | 1.47 |
| Debt / Equity | 1.40 |
| Debt / EBITDA | 2.88 |
| Debt / FCF | 14.51 |
| Interest Coverage | 6.72 |
Financial Efficiency
Return on equity (ROE) is 19.66% and return on invested capital (ROIC) is 6.26%.
| Return on Equity (ROE) | 19.66% |
| Return on Assets (ROA) | 4.75% |
| Return on Invested Capital (ROIC) | 6.26% |
| Return on Capital Employed (ROCE) | 8.99% |
| Revenue Per Employee | $254,038 |
| Profits Per Employee | $8,235 |
| Employee Count | 24,900 |
| Asset Turnover | 1.27 |
| Inventory Turnover | 23.15 |
Taxes
In the past 12 months, Ardent Health has paid $64.47 million in taxes.
| Income Tax | 64.47M |
| Effective Tax Rate | 17.85% |
Stock Price Statistics
The stock price has decreased by -45.38% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -45.38% |
| 50-Day Moving Average | 12.77 |
| 200-Day Moving Average | 13.08 |
| Relative Strength Index (RSI) | 26.65 |
| Average Volume (20 Days) | 808,055 |
Short Selling Information
The latest short interest is 2.75 million, so 1.92% of the outstanding shares have been sold short.
| Short Interest | 2.75M |
| Short Previous Month | 2.92M |
| Short % of Shares Out | 1.92% |
| Short % of Float | 11.22% |
| Short Ratio (days to cover) | 5.07 |
Income Statement
In the last 12 months, Ardent Health had revenue of $6.33 billion and earned $205.06 million in profits. Earnings per share was $1.44.
| Revenue | 6.33B |
| Gross Profit | 3.67B |
| Operating Income | 378.40M |
| Pretax Income | 361.23M |
| Net Income | 205.06M |
| EBITDA | 530.92M |
| EBIT | 378.40M |
| Earnings Per Share (EPS) | $1.44 |
Balance Sheet
The company has $614.32 million in cash and $2.28 billion in debt, giving a net cash position of -$1.67 billion or -$11.66 per share.
| Cash & Cash Equivalents | 614.32M |
| Total Debt | 2.28B |
| Net Cash | -1.67B |
| Net Cash Per Share | -$11.66 |
| Equity (Book Value) | 1.63B |
| Book Value Per Share | 8.65 |
| Working Capital | 1.01B |
Cash Flow
In the last 12 months, operating cash flow was $366.64 million and capital expenditures -$209.18 million, giving a free cash flow of $157.46 million.
| Operating Cash Flow | 366.64M |
| Capital Expenditures | -209.18M |
| Free Cash Flow | 157.46M |
| FCF Per Share | $1.10 |
Margins
Gross margin is 57.94%, with operating and profit margins of 5.98% and 3.24%.
| Gross Margin | 57.94% |
| Operating Margin | 5.98% |
| Pretax Margin | 5.71% |
| Profit Margin | 3.24% |
| EBITDA Margin | 8.39% |
| EBIT Margin | 5.98% |
| FCF Margin | 2.49% |
Dividends & Yields
Ardent Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.52% |
| Shareholder Yield | -9.52% |
| Earnings Yield | 16.04% |
| FCF Yield | 12.31% |
Analyst Forecast
The average price target for Ardent Health is $14.70, which is 64.61% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.70 |
| Price Target Difference | 64.61% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 7.14% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ardent Health has an Altman Z-Score of 2.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.18 |
| Piotroski F-Score | 6 |